Antares Pharma, Inc. (ATRS) financial statements (2020 and earlier)

Company profile

Business Address 100 PRINCETON SOUTH
EWING, NJ 08628
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments42283228484063
Cash and cash equivalents42282728333439
Short-term investments  5 15624
Receivables3419129841
Inventory, net of allowances, customer advances and progress billings171195666
Inventory171195666
Contract with customer, asset610
Deferred costs  12120
Other undisclosed current assets1321322
Total current assets:100715645665473
Noncurrent Assets
Operating lease, right-of-use asset5
Property, plant and equipment1515161815117
Long-term investments and receivables      6
Long-term investments      6
Intangible assets, net (including goodwill)2223442
Goodwill1111111
Intangible assets, net (excluding goodwill)1112231
Other noncurrent assets1000001
Total noncurrent assets:23171921191516
TOTAL ASSETS:123887466856989
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities31231314121714
Accounts payable1711685106
Accrued liabilities151276665
Employee-related liabilities     22
Deferred revenue1
Debt13     
Deferred revenue and credits36595
Contract with customer, liability1
Other undisclosed current liabilities     (2)(2)
Total current liabilities:34271620172416
Noncurrent Liabilities
Long-term debt and lease obligation452225    
Long-term debt, excluding current maturities402225    
Operating lease, liability4
Liabilities, other than long-term debt  01132
Deferred revenue and credits01132
Total noncurrent liabilities:4522251132
Total liabilities:79494121182818
Stockholders' equity
Stockholders' equity attributable to parent, including:44393445674171
Additional paid in capital327315303298295249243
Accumulated other comprehensive loss(1)(1)(1)(1)(1)(1)(1)
Accumulated deficit(283)(277)(270)(253)(229)(208)(173)
Other undisclosed stockholders' equity attributable to parent2222211
Total stockholders' equity:44393445674171
TOTAL LIABILITIES AND EQUITY:123887466856989

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues105645552462721
Revenue, net5552462721
Cost of revenue
(Cost of Goods and Services Sold)
(46)(31)(27)(29)(19)(11)(9)
Gross profit:59322723261511
Operating expenses(57)(37)(44)(48)(47)(50)(32)
Operating income (loss):2(4)(16)(24)(20)(35)(21)
Nonoperating income (expense)(2)(2)(0)(0)(0)(0)0
Foreign currency transaction gain (loss), before tax   (0)(0)0(0)
Other nonoperating income (expense)000(0)(0)(0)(0)
Interest and debt expense(3)(3)(1)    
Loss from continuing operations before equity method investments, income taxes:(3)(9)(18)(24)(20)(35)(21)
Other undisclosed income from continuing operations before income taxes331    
Loss from continuing operations before income taxes:(1)(7)(17)(24)(20)(35)(21)
Income tax expense (benefit)   (0)(0)(0)0
Net loss available to common stockholders, diluted:(1)(7)(17)(24)(21)(35)(21)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(1)(7)(17)(24)(21)(35)(21)
Other comprehensive income (loss)(0)(0)0(0)0(0)0
Other undisclosed comprehensive loss(0)      
Comprehensive loss:(1)(7)(17)(24)(21)(35)(20)
Other undisclosed comprehensive income, net of tax, attributable to parent0      
Comprehensive loss, net of tax, attributable to parent:(1)(7)(17)(24)(21)(35)(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: